China Shineway Pharmaceutical Group Limited
CSWYF
$0.9398
$0.07378.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.48% | -65.51% | -0.86% | 31.80% | 0.31% |
| Total Depreciation and Amortization | 0.48% | -114.97% | -0.86% | 413.65% | -0.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.48% | 82.62% | 0.86% | -205.91% | 0.31% |
| Change in Net Operating Assets | -0.48% | -- | -- | -- | 0.32% |
| Cash from Operations | -0.48% | -28.45% | -0.86% | -7.19% | 0.31% |
| Capital Expenditure | 0.48% | 10.91% | 0.86% | 21.28% | -0.31% |
| Sale of Property, Plant, and Equipment | -0.47% | -17.58% | -0.83% | -9.79% | 0.30% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -0.49% | -- | -- | -- | -- |
| Other Investing Activities | 0.48% | -294.00% | -0.86% | 58.81% | 0.31% |
| Cash from Investing | 0.48% | -547.00% | -0.86% | 2,090.95% | 0.32% |
| Total Debt Issued | -- | -100.00% | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | 98.61% | 0.00% | -8,118.03% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.48% | 74.12% | 0.86% | -293.14% | -0.31% |
| Other Financing Activities | 0.00% | -19.88% | 0.00% | -17.66% | 0.00% |
| Cash from Financing | 0.48% | 69.58% | 0.86% | -240.13% | -0.31% |
| Foreign Exchange rate Adjustments | 0.48% | -1,328.71% | -0.85% | 385.84% | -0.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.48% | -127.71% | -0.86% | -33.58% | 0.31% |